Spine length may help prevent blood pressure drops during C-Sections
NCT ID NCT06869434
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether using the length of the lower spine to calculate spinal anesthesia dose during C-sections could lower the risk of a dangerous drop in blood pressure. 446 women were randomly assigned to receive a dose based on spine length or standard height-based dosing. The goal was to see which method led to fewer cases of low blood pressure during surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If successful, this dosing method could reduce the risk of dangerously low blood pressure during C-sections, making spinal anesthesia safer.
- What could go wrong
- This is a completed study, but the approach may not work for all patients or settings. The results need confirmation in broader populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
446 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. American Society of Anesthesiologists (ASA) Class II 2. Having regular antenatal visits 3. Singleton pregnancy at ≥37 weeks of gestation 4. Pregnant women aged 18-45 - Exclusion Criteria: 1. Those with eclampsia, those with preeclampsia 2. Undergoing an emergency cesarean section 3. Those with bleeding diathesis and those receiving anticoagulant therapy 4. With a history of carotid artery stenosis, 5. Cardiovascular disease, 6. Hypertension, 7. Chronic obstructive pulmonary disease, 8. Heart rhythm outside of sinus 9. Patients with a history of cerebrovascular disease 10. Alcoholism or psychiatric illness 11. Placenta previa, accreta, and percreta
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bupivacaine adverse reaction are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kudret Doğru
Kayseri, Melikgazi, 38050, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.